Literature DB >> 2317491

Interactions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphiphiles.

R Leventis1, J R Silvius.   

Abstract

Several novel cationic amphiphiles, based on a hydrophobic cholesteryl or dioleoylglyceryl moiety, have been prepared whose hydrophobic and cationic portions are linked by ester bonds to facilitate efficient degradation in animal cells. Dispersions combining such cationic species with phosphatidylethanolamine (PE), certain structural analogues of PE or diacylglycerol can mediate efficient transfer of both nonexchangeable lipid probes and the DNA plasmid pSV2cat into cultured mammalian (CV-1 and 3T3) cells. The abilities of different types of cationic lipid dispersions to mediate transfection of mammalian cells with pSV2cat could not be directly correlated with their abilities to coalesce with other membranes, as assessed by their ability to intermix lipids efficiently with large unilamellar phosphatidylcholine/phosphatidylserine vesicles in the presence or absence of DNA. The cytotoxicities toward CV-1 cells of dispersions combining PE with most of the degradable cationic amphiphiles studied here compare favorably with those reported previously for similar dispersions containing other types of cationic amphiphiles. Fluorescent analogues of two of the diacylglycerol-based cationic amphiphiles examined in this study are shown to be readily degraded after incorporation into CV-1 cells from PE/cationic lipid dispersions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2317491     DOI: 10.1016/0005-2736(90)90017-i

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  60 in total

1.  Gastroprotection of DNA with a synthetic cholic acid analog.

Authors:  E J Niedzinski; M J Bennett; D C Olson; M H Nantz
Journal:  Lipids       Date:  2000-07       Impact factor: 1.880

2.  Targeted delivery of oligodeoxynucleotides to parenchymal liver cells in vivo.

Authors:  E A Biessen; H Vietsch; E T Rump; K Fluiter; J Kuiper; M K Bijsterbosch; T J van Berkel
Journal:  Biochem J       Date:  1999-06-15       Impact factor: 3.857

3.  Lipoplex thermodynamics: determination of DNA-cationic lipoid interaction energies.

Authors:  Edwin Pozharski; Robert C MacDonald
Journal:  Biophys J       Date:  2003-12       Impact factor: 4.033

4.  Thermodynamics of cationic lipid-DNA complex formation as studied by isothermal titration calorimetry.

Authors:  Edwin Pozharski; Robert C MacDonald
Journal:  Biophys J       Date:  2002-07       Impact factor: 4.033

5.  Surface charge density determines the efficiency of cationic gemini surfactant based lipofection.

Authors:  Samppa J Ryhänen; Matti J Säily; Tommi Paukku; Stefano Borocci; Giovanna Mancini; Juha M Holopainen; Paavo K J Kinnunen
Journal:  Biophys J       Date:  2003-01       Impact factor: 4.033

Review 6.  Lipoplex-mediated delivery of nucleic acids: factors affecting in vivo transfection.

Authors:  Crispin R Dass
Journal:  J Mol Med (Berl)       Date:  2004-06-23       Impact factor: 4.599

Review 7.  Action and reaction: the biological response to siRNA and its delivery vehicles.

Authors:  Rosemary L Kanasty; Kathryn A Whitehead; Arturo J Vegas; Daniel G Anderson
Journal:  Mol Ther       Date:  2012-01-17       Impact factor: 11.454

Review 8.  Cationic liposome/DNA complexes: from structure to interactions with cellular membranes.

Authors:  Giulio Caracciolo; Heinz Amenitsch
Journal:  Eur Biophys J       Date:  2012-06-19       Impact factor: 1.733

9.  Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: a stage toward artificial viruses.

Authors:  J S Remy; A Kichler; V Mordvinov; F Schuber; J P Behr
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

10.  Overcoming nonviral gene delivery barriers: perspective and future.

Authors:  Charles H Jones; Chih-Kuang Chen; Anitha Ravikrishnan; Snehal Rane; Blaine A Pfeifer
Journal:  Mol Pharm       Date:  2013-10-16       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.